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Summary  The  MR  is  an  important  regulator  of  the  hypothalamic—pituitary—adrenal  (HPA)
axis and  a  prime  target  for  corticosteroids.  There  is  increasing  evidence  from  both  clin-
ical and  preclinical  studies  that  the  MR  has  different  effects  on  behavior  and  mood  in
males and  females.  To  investigate  the  hypothesis  that  the  MR  sex-dependently  inﬂuences
the relation  between  childhood  maltreatment  and  depression,  we  investigated  three  com-
mon and  functional  MR  haplotypes  (GA,  CA,  and  CG  haplotype,  based  on  rs5522  and
rs2070951) in  a  population-based  cohort  (N  =  665)  and  an  independent  clinical  cohort  from
the Netherlands  Study  of  Depression  and  Anxiety  (NESDA)  (N  =  1639).  The  CA  haplotype
sex-dependently  moderated  the  relation  between  childhood  maltreatment  and  depressive
symptoms  both  in  the  population-based  sample  (sex  ×  maltreatment  ×  haplotype:  ˇ  =  −4.07,
P =  0.029)  and  in  the  clinical  sample  (sex  ×  maltreatment  ×  haplotype,  ˇ  =  −2.40,  P  =  0.011).
Speciﬁcally,  female  individuals  in  the  population-based  sample  were  protected  (ˇ  =  −4.58,
P =  2.0e−5),  whereas  males  in  the  clinical  sample  were  at  increased  risk  (ˇ  =  2.54,  P  =  0.0022).
In line  with  these  results,  female  GA  haplotype  carriers  displayed  increased  vulnerabil-
ity in  the  population-based  sample  (ˇ  =  4.58,  P  =  7.5e−5)  whereas  male  CG-carriers  showed
increased  resilience  in  the  clinical  sample  (ˇ  =  −2.71,  P  =  0.016).  Consistently,  we  found
a decreased  lifetime  MDD  risk  for  male  GA  haplotype  carriers  following  childhood  mal-
treatment but  an  increased  risk  for  male  CA  haplotype  carriers  in  the  clinical  sample.
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21. Introduction
The  hypothalamic—pituitary—adrenal  (HPA)  axis  is  essential
for  successful  adaptation  to  stress.  However,  stress  expo-
sure,  especially  early  in  life,  is  also  a  major  risk  factor
for  psychiatric  disorders.  Both  mineralocorticoid  (MR)  and
glucocorticoid  receptors  (GR)  are  involved  in  HPA-axis  reg-
ulation  and  constitute  primary  targets  for  its  end  product
corticosteroids  (de  Kloet  et  al.,  2005).  Whereas  the  role  of
the  GR  has  received  ample  attention,  the  MR  has  remained
relatively  unexplored.  This  may  be  due  to  the  fact  that  corti-
sol  binds  with  high  afﬁnity  to  the  MR,  resulting  in  substantial
occupancy  even  under  non-stressful  circumstances  (Joëls
et  al.,  2008).  Therefore,  MRs  were  primarily  thought  to  facil-
itate  GR  functionality  by  cortisol  binding  (i.e.,  a  cortisol
‘‘chelator’’).  However,  there  is  increasing  evidence  that  the
MR  plays  a  pivotal  role  in  HPA-axis  functionality  and  deter-
mines  susceptibility  for  stress-related  psychiatric  disorders
(Ter  Heegde  et  al.,  2015;  Klok  et  al.,  2011b;  Otte  et  al.,
2010;  Van  Leeuwen  et  al.,  2011;  Berardelli  et  al.,  2013).  In
addition  to  the  genomic  MR,  MRs  located  in  the  vicinity  of
the  membrane  and  active  with  high  hormone  concentrations
were  recently  shown  to  mediate  rapid  cortisol  effects  and
inﬂuence  stress  appraisal  (Karst  et  al.,  2010).  These  ﬁndings
have  put  the  MR  forward  as  an  important  mediator  of  stress
effects  in  the  brain  and  point  to  a  role  for  the  MR  in  sus-
ceptibility  for  depression  (DeRijk  et  al.,  2008;  Ter  Heegde
et  al.,  2015).  The  MR  may  be  particularly  important  follow-
ing  childhood  maltreatment  which  is  a  well-established  risk
factor  for  depression  and  associated  with  persistent  changes
in  HPA-axis  functionality  (Heim  et  al.,  1997,  2008).
Several  converging  lines  of  evidence  indicate  that
MR-mediated  susceptibility  for  psychiatric  disorders  may  be
sex-dependent.  First,  a  recent  clinical  study  showed  that
resilience  to  depression  associated  with  a  functional  MR
haplotype  was  only  present  in  females  (Klok  et  al.,  2011c).
Second,  preclinical  studies  suggest  that  MR  expression  levels
have  sex-dependent  consequences  on  fear  memory  (Ter
Horst  et  al.,  2012)  and  decision  making  (Ter  Horst  et  al.,
2014).  Also,  chronic  stress  sex-dependently  modulates  MR
expression  (Karandrea  et  al.,  2000;  Kitraki  et  al.,  2004).
Third,  sex-dependent  MR  effects  are  biologically  plausible
in  light  of  MR  afﬁnity  for  the  female  steroid  hormone  pro-
gesterone  (Carey  et  al.,  1995;  Quinkler  et  al.,  2002),  which
can  in  turn  alter  MR  expression  (Castrén  et  al.,  1995;  Turner,
1990).  Together,  these  data  support  evidence  that  the  role
of  the  MR  may  be  sex-dependent.  These  sex  differences
are  important  in  light  of  consistent  gender  differences
in  the  prevalence  of  stress-related  psychiatric  disorders
(Cyranowski  et  al.,  2000;  Piccinelli  and  Wilkinson,  2000).
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ffects  were  observed  for  GA-GA  diplotype  carriers.  In  summary,
rmining  whether  functional  genetic  variation  in  MR  is  beneﬁcial
 female  advantage  for  the  CA  haplotype  but  male  advantage
ese  sex-dependent  effects  of  MR  on  depression  susceptibility
t  are  relevant  in  light  of  the  increased  prevalence  of  mood
 sex-speciﬁc  role  of  MR  in  the  etiology  of  depression  following
erved.
oreover,  even  though  often  overlooked,  consistent
ex  differences  exist  in  the  endocrine  stress  response
Kudielka  and  Kirschbaum,  2005).
This  study  aimed  to  investigate  whether  common  and
unctional  genetic  variation  in  the  MR  would  dependently
oderate  the  relation  between  childhood  maltreatment  and
epressive  symptoms  in  a  general  population  sample  and  an
ndependent  clinical  sample  from  the  Netherlands  Study  of
epression  and  Anxiety  (NESDA).  Haplotype  analysis  based
n  exonic  sequencing  of  the  MR  gene  NR3C2  in  ﬁfty  Dutch
ndividuals  has  shown  that  three  common  MR  haplotypes
xist  in  the  5′ region  based  on  the  single  nucleotide  polymor-
hisms  rs2070951  and  rs5522  (Van  Leeuwen,  2010).  MR-2C/G
rs2070951)  is  located  2  nucleotides  before  the  transla-
ion  site  of  exon  2,  and  MRI180V  (rs5522)  is  located  within
xon  2.  Both  SNPs  affect  in  vitro  transactivation  by  altering
ither  MR  expression  or  functionality.  MRI180V  substitutes
soleucine  (A)  for  valine  (G)  in  the  N-terminal  of  the  MR  pro-
ein  and  in  vitro  testing  shows  that  the  Val-allele  results  in
 mild  loss  of  function  compared  to  the  Iso-allele  (DeRijk
t  al.,  2006;  Van  Leeuwen  et  al.,  2011).  The  MR-2C/G  SNP
s  located  outside  the  MR  coding  region  but  inside  a  Kozac
ranslation  regulatory  sequence  which  regulates  MR  tran-
cription.  C-allele  carriers  have  an  increased  MR  expression
Leeuwen  et  al.,  2010).  MRI180V  and  MR-2C/G  are  in  low
inkage  disequilibrium  (r2 =  0.11),  and  the  combination  of
hese  2  SNPs  results  in  three  common  MR  haplotypes  in  the
eneral  population  (DeRijk  et  al.,  2008).  These  three  com-
on  MR  haplotypes  differentially  affect  MR  activity  and  are
herefore  appropriate  to  investigate  the  effects  of  func-
ional  genetic  MR  variation  in  humans  (Klok  et  al.,  2011c;
an  Leeuwen  et  al.,  2011).  Based  on  the  known  protec-
ive  effects  of  the  CA  haplotype  speciﬁcally  in  females  but
ot  in  males  (Klok  et  al.,  2011c),  we  hypothesized  that
or  maltreatment-related  depression,  a  similar  protective
ffect  would  be  present  in  females  and  not  in  males.  We
urther  hypothesized  that  the  other  MR  haplotypes  would
ave  the  opposite  effect  and  would  be  associated  with  an
ncreased  vulnerability  in  females.
.  Methods
.1.  Samples
.1.1.  Population-based  sample
articipants  in  the  population-based  sample  were  recruited
sing  a  website  targeted  at  Dutch  young  adults  and  ado-
escents  from  18  to  25  years  (www.cannabisquest.nl).
etails  on  recruitment  and  veriﬁcation  strategies  have  been
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reviously  published  (Van  Gastel  et  al.,  2012).  Of  the  1259
articipants  that  completed  comprehensive  assessments
nd  provided  blood  samples  for  genetic  testing,  complete
ata  were  available  for  665  subjects  due  to  a  later  imple-
entation  of  the  Childhood  Trauma  Questionnaire  (CTQ)
ssessment.  All  participants  provided  a  urine  sample  in  order
o  verify  recent  self-reported  cannabis  use.  The  study  was
pproved  by  the  Ethical  Review  Board  of  the  University
edical  Center  Utrecht  and  all  participants  gave  written
nformed  consent.
.1.2.  Clinical  sample
he  clinical  sample  consisted  of  data  from  the  Netherlands
tudy  of  Depression  and  Anxiety  (NESDA),  a  large  ongo-
ng  cohort  study  on  the  course  of  depressive  and  anxiety
isorders.  A  description  of  the  study  rationale,  design,
nd  methods  is  given  elsewhere  (Penninx  et  al.,  2008).
rieﬂy,  in  2004—2007  participants  aged  18  to  65  years  were
ecruited  from  the  community  (19%),  general  practice  (54%)
nd  secondary  mental  health  care  (27%).  A  total  of  2981
articipants  were  included,  consisting  of  persons  with  a  cur-
ent  or  past  depressive  and/or  anxiety  disorder  and  healthy
ontrols.  Psychiatric  diagnoses  according  to  DSM-IV  criteria
ere  established  with  the  lifetime  version  of  the  Composite
nternational  Diagnostic  Interview  (CIDI  2.1).  The  research
rotocol  was  approved  by  the  Ethical  Review  Board  of  par-
icipating  universities  and  all  respondents  provided  written
nformed  consent.  Analyses  were  performed  on  the  total
ample  for  which  genetic  data  were  available  (N  =  1639)  with
epressive  symptoms  (IDS)  as  outcome  in  order  to  directly
ompare  the  population-based  sample  with  the  clinical  sam-
le  (Table  1).  Moreover,  to  investigate  whether  the  risk  for
DD  would  be  increased  over  a  longer  time  period,  lifetime
DD  diagnosis  was  also  used  as  outcome.
.2.  Measures
.2.1.  Childhood  maltreatment
hildhood  maltreatment  was  assessed  using  the  25-item  ver-
ion  of  the  Childhood  Trauma  Questionnaire  (CTQ)  in  the
opulation-based  sample  (Bernstein  and  Fink,  1998).  The
TQ  assesses  ﬁve  types  of  self-report  childhood  trauma:
motional,  physical,  and  sexual  abuse,  and  emotional  and
hysical  neglect.  The  validity  of  the  CTQ,  including  a  Dutch
ranslation,  has  been  demonstrated  in  clinical  and  com-
unity  samples  (Bernstein  and  Fink,  1998;  Thombs  et  al.,
009).  One  translated  item  (‘‘I  believe  I  was  molested’’)
as  excluded  in  the  discovery  sample  as  this  translation
as  found  to  be  an  invalid  indicator  of  childhood  sexual
buse  in  a  previous  validation  study  (Thombs  et  al.,  2009).  In
he  population-based  sample,  childhood  maltreatment  was
sed  as  the  continuous  sum  score  divided  by  the  number
f  completed  items.  In  the  clinical  NESDA  sample,  child-
ood  trauma  was  assessed  using  a  semi-structured  childhood
rauma  interview  also  used  in  the  Netherlands  Mental  Health
urvey  and  Incidence  Study  (NEMESIS)  (for  details,  see
De  Graaf  et  al.,  2002)).  Participants  were  asked  whether
hey  had  experienced  any  kind  of  emotional  neglect,
sychological,  physical  or  sexual  abuse  before  the  age
f  16.  Subsequently,  a  self-constructed  childhood  trauma
ndex  (sum  scores  of  frequency  ranging  from  0  to  8)  was
a
c
e
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alculated  with  a  higher  score  indicating  more  types  and  a
igher  frequency  of  childhood  trauma  (Hovens  et  al.,  2012).
hese  scores  were  subsequently  categorized  into  ﬁve  cate-
ories:  0  =  0,  1  =  1—2,  2  =  3—4,  3  =  5—6,  and  4  =  7—8.
.2.2.  Depressive  symptoms  and  MDD
n  the  population-based  sample,  depressive  symptoms  were
ssessed  with  the  Beck  Depression  Inventory  (BDI).  This
alidated  21-item  self-report  questionnaire  measures  cur-
ent  depressive  symptoms  during  the  last  week  with  a  total
core  ranging  from  0  to  63.  In  order  to  allow  the  compar-
son  to  the  population-based  sample,  depressive  symptoms
ver  the  past  week  were  used  as  outcome  in  the  clinical
ample  as  assessed  with  the  self-report  30-item  Inven-
ory  of  Depressive  Symptomatology  (IDS-SR30)  (Rush  et  al.,
996).  Moreover,  the  presence  of  a  lifetime  MDD  diagnosis
assessed  using  the  CIDI  which  was  conducted  by  trained  clin-
cal  research  staff)  was  also  used  as  outcome  to  examine
hether  the  MR  was  associated  with  maltreatment-related
DD  across  the  life  span.
.2.3.  Mineralocorticoid  receptor  haplotypes  and
iplotypes
R  haplotypes  were  calculated  based  on  the  2G/C
rs2070951)  and  I180V  (rs5522)  SNPs  in  the  MR  pro-
oter  region.  These  haplotypes  display  differential  activity
t  the  transcriptional,  translational  and  transactivational
evel  (Klok  et  al.,  2011b;  Van  Leeuwen  et  al.,  2011).  In
he  population-based  sample,  SNP  data  were  extracted
s  previously  described  (Vinkers  et  al.,  2013).  In  short,
enotype  data  were  generated  on  three  different  array
latforms:  the  IlluminaHumanOmniExpress  (N  =  576),  the
lluminaHuman610-QuadBeadchip  (N  =  768),  and  the  Illumi-
aHumanHap550  array  (N  =  34)  and  extensive  quality  control
as  subsequently  carried  out.  All  participants  were  of
utch  ancestry.  From  these  data,  the  2G/C  (rs2070951)  and
180V  (rs5522)  SNPs  were  extracted.  In  the  clinical  sam-
le,  genotyping  was  performed  on  multiple  chip  platforms
n  partially  overlapping  different  subsets  of  the  total  sam-
le  (Affymetrix-Perlegen  5.0  and  Affymetrix  6.0)  and  data
ere  imputed  using  the  1000  Genomes  phase  1  Integrated
elease  Version  3  All  panel.  All  post-imputation  QC  criteria
ere  met;  r2hat  values  were  0.87  for  rs2070951  and  0.88
or  rs5522.  SNP  allele  frequencies  were  tested  for  devia-
ions  from  the  Hardy—Weinberg  Equilibrium.  To  investigate
he  contribution  of  speciﬁc  combinations  of  haplotypes,
iplotypes  (the  speciﬁc  combination  of  haplotypes)  were
alculated  for  each  individual.
.2.4.  Covariates
ex  and  age  were  used  as  covariates  in  all  analysis.
annabis  use  was  included  as  covariate  in  analyses  in  the
opulation-based  sample  as  this  cohort  was  originally  set
p  to  investigate  the  effects  of  cannabis  on  mental  health.
urrent  cannabis  use  was  deﬁned  as  use  more  than  an  equiv-
lent  of  3  euros  per  week  (roughly  equivalent  to  weekly
annabis  use)  during  the  last  month  or  longer  (Schubart
t  al.,  2011).  Exclusion  of  cannabis  use  in  the  analyses  did
ot  change  any  of  the  results.
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Table  1  Characteristics  of  the  population-based  sample  and  clinical  sample.  MAF:  minor  allele  frequency.
Parameter  Population-based  sample  (N  =  665)  Clinical  sample  (N  =  1639)  Differences
Female  sex  (%)  56  66  P  <  0.001
Age, mean  (range)  (y)  21  (18—40)  42  (18—65)  P  <  0.001
Cannabis use  in  the  past  year  (>3D /week  (%))  28  N/A  N/A
Depressive symptoms  (BDI/IDS),  mean  (range)  5.4  (0—34)  22.4  (0—69)  P  <  0.001
Lifetime MDD  (%)  N/A  79%  N/A
Childhood maltreatment,  mean  (range)  1.39  (1.00—4.26)  0.97  (0—4)  N/A*
rs5522  (MAF  (%)) 11  12  NS
rs2070951 (MAF  (%)) 46  49  NS
MR GA  (1)  haplotype  (%) 54  51  NS
0 Copies 22.6  22.4
1 Copy  47.6  52.7
2 Copies  29.8  25.0
MR CA  (2)  haplotype  (%)  35  37  NS
0 Copies  42.1  38.4
1 Copy  45.7  49.4
2 Copies  12.1  12.2
MR CG  (3)  haplotype  (%)  11  12  NS
0 Copies  78.0  78.1
1 Copy  21.2  20.2
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* Different childhood maltreatment scales.
2.3.  Statistical  analysis
To  examine  the  interaction  between  MR  haplotypes,  sex,
and  childhood  maltreatment  on  depressive  symptoms,
the  total  depression  score  was  regressed  on  childhood
maltreatment,  MR  haplotype,  their  interaction,  and
covariates  using  the  following  model:  Depressive  symp-
toms  =  ˇ0 +  (ˇ1 ×  covariate)  +  (ˇ2 ×  haplotype)  +  (ˇ3 ×  sex)  +  (ˇ
maltreatment)  +  (ˇ5 ×  haplotype  ×  childhood  mal-
treatment)  +  (ˇ6 ×  haplotype  ×  sex)  +  (ˇ7 ×  childhood
maltreatment  ×  sex)  +  (ˇ8 ×  haplotype  ×  childhood  mal-
treatment  ×  sex).  Also,  logistic  regression  analyses  were
also  carried  out  in  the  clinical  sample  with  lifetime  MDD
diagnosis  as  outcome.  Preplanned  separate  analyses  of  male
and  female  individuals  were  carried  out  to  investigate  the
directionality  of  the  MR  effects  between  sexes.  Addition-
ally,  to  investigate  how  sex-dependency  would  inﬂuence
the  interaction  between  the  MR  haplotypes  and  childhood
maltreatment,  we  carried  out  test  of  models  ﬁt  with  and
without  sex  as  a  factor  with  a  likelihood  ratio  test.
Included  covariates  were  age  (in  both  samples)  and
cannabis  use  (in  the  population-based  sample  only,  modeled
as  a  dichotomous  indicator).  MR  haplotypes  were  coded  0,  1,
or  2  and  modeled  as  a  linear  effect  (additive  genetic  model)
to  account  for  different  genotype  distributions.  MR  diplo-
types  (the  combination  of  2  haplotypes  per  individual)  were
constructed  by  combinations  of  the  three  haplotypes  and
analyzed  relative  to  the  largest  diplotype  group  (GA—CA)
using  dummy  coding.  Continuous  sum  scores  of  childhood
maltreatment  were  used  in  both  samples.  Causal  inference
of  sex-dependent  GA  haplotype  effects  was  analyzed  using
the  mediation  package  (Tingley  et  al.,  2014)  with  haplo-
types  collapsed  to  two  equal  groups  with  1000  permutations.
All  analyses  were  performed  in  R  (www.r-project.org).  As
haplotype  inference  is  based  on  previous  functional  studies
M
t
(
t1.7
hildhood
f  the  MR  and  these  haplotypes  are  not  independent,  we
efrained  from  multiple  testing  correction.
.  Results
.1.  Sample  characteristics
haracteristics  of  the  population-based  and  clinical  sam-
le  are  summarized  in  Table  1.  On  average,  participants  in
he  clinical  sample  were  older  compared  to  the  population-
ased  sample  (P  <  0.001).  SNP  allele  frequencies  did  not
eviate  from  Hardy—Weinberg  Equilibrium  in  both  samples
all  P-values  >0.10,  Table  2)  and  are  in  line  with  published
ata  (Klok  et  al.,  2011c;  Van  Leeuwen  et  al.,  2011).  Three
R  haplotypes  were  found  in  both  samples  which  is  com-
arable  to  the  published  literature  (Klok  et  al.,  2011c;  Van
eeuwen  et  al.,  2011)  (Table  1).  Six  different  combinations
f  haplotype  (diplotypes)  were  present  with  comparable  fre-
uencies  across  samples  with  the  GA—CA  diplotype  being
he  most  prevalent  (population-based  sample:  37%;  clinical
ample:  55%),  followed  by  the  GA—GA  diplotype  (population-
ased  sample:  29%;  clinical  sample:  18%)  (Supplementary
able  S1).
.2.  Sex-dependence  of  MR  haplotypes  on
epressive symptoms  in  the  population-based
ample
able  2  shows  the  results  of  the  linear  regression
odel  in  the  population-based  sample  for  the  three
R  haplotypes.  The  association  between  childhood  mal-
reatment,  MR  haplotype,  and  depressive  symptoms
BDI  score)  was  sex-dependent  for  the  GA  haplo-
ype  (sex  ×  maltreatment  ×  haplotype  ˇ  =  3.73,  P  =  0.040,
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Table  2  The  relation  between  MR  haplotypes,  sex,  and  childhood  maltreatment  on  depressive  symptoms  in  the  population-based
sample (N  =  665)  for  the  GA  haplotype  (A),  the  CA  haplotype  (B),  and  the  CG  haplotype  (C).
(A)  MR  GA  (1)  haplotype
Beta  SE  t-Value  P  value
Intercept  −1.42 3.13  −0.45  0.65
Sex 4.20 3.26 1.29  0.20
Age −0.05 0.09 −0.49 0.62
Childhood  maltreatment  (CM)  5.40  0.09  2.93  0.003**
GA  haplotype  −1.91  2.04  −0.94  0.35
Cannabis use  1.08  0.56  1.93  0.054
Sex ×  maltreatment  −3.30  2.25  −1.47  0.14
Sex ×  GA  haplotype  −3.80  2.58  −1.47  0.14
Maltreatment  ×  GA  haplotype  0.92  1.43  0.64  0.52
Sex ×  maltreatment  ×  GA  haplotype  3.73  1.81  2.06  0.040*
(B)  MR  CA  (2)  haplotype
Intercept  −4.71  2.94  −1.60  0.11
Sex −2.83  2.84  −1.00  0.32
Age −0.04  0.09  −0.47  0.64
Childhood maltreatment 6.83 1.65  4.12  <0.001***
MR  CA  haplotype 1.73  2.15  0.80  0.42
Cannabis 1.14 0.55  2.06  0.040*
Sex  ×  maltreatment 3.94  2.03  1.94  0.052
Sex ×  CA  haplotype 3.47 2.65  1.31  0.19
Maltreatment  ×  CA  haplotype −0.67 1.53 −0.44  0.66
Sex ×  maltreatment  ×  CA  haplotype −4.07 1.86 −2.19 0.029*
(C)  MR  CG  (3)  haplotype
Intercept  −4.47  2.51  −1.78  0.08
Sex 1.26  2.08  0.61  0.55
Age −0.005  0.09  −0.05  0.96
Childhood maltreatment  6.50  1.21  5.36  <0.001***
MR  CG  haplotype  1.24  4.09  0.30  0.76
Cannabis 1.23  0.57  2.17  0.031*
Sex  ×  maltreatment  −0.40  1.45  −0.28  0.78
Sex ×  CG  haplotype  −2.44  4.98  −0.49  0.62
Maltreatment  ×  CG  haplotype  −1.11  2.98  −0.37  0.71
Sex ×  maltreatment  ×  CG  haplotype  2.96  3.58  0.83  0.41
* P < 0.05.
** P < 0.01.
***
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ig.  1A)  and  CA  haplotype  (sex  ×  maltreatment  ×  haplotype
 =  −4.07,  P  =  0.029),  but  not  for  the  relatively  infrequent
G  haplotype  (sex  ×  maltreatment  ×  haplotype,  ˇ  =  2.96,
 =  0.41).  Childhood  maltreatment  was  signiﬁcantly  associ-
ted  with  depressive  symptoms  in  all  analyses  (P  <  0.01).
xclusion  of  cannabis  use  in  the  model  did  not  change
ny  of  the  results.  Analysis  of  the  separate  SNPs
howed  that  the  three-way  interaction  between  sex,
altreatment  and  the  separate  SNPs  was  signiﬁcant
or  rs2070951  (sex  ×  maltreatment  ×  rs2070951  interaction,
 =  0.040)  but  not  rs5522  (sex  ×  maltreatment  ×  rs5522
nteraction,  P  =  0.41).
Subsequently,  we  analyzed  male  and  female  individuals
eparately.  For  females,  the  GA  haplotype  was  associ-
ted  with  increased  depressive  symptoms  after  childhood
a
t
i
<altreatment  in  females  (ˇ  =  4.58,  P  =  7.5e−5),  whereas
emale  CA  haplotype  carriers  were  protected  (ˇ  =  −4.58,
 =  2.0e−5).  In  contrast,  no  signiﬁcant  main  effect  was
ound  in  male  individuals  for  the  GA  haplotype  (haplotype:
 =  −2.17,  P  =  0.26;  maltreatment  ×  haplotype  interaction:
 =  1.03,  P  =  0.45)  or  the  CA  haplotype  (haplotype:  ˇ  =  1.91,
 =  0.36;  maltreatment  ×  haplotype  interaction:  ˇ  =  1.47,
 =  0.62).  For  the  CG  haplotype,  separate  analysis  of  male
nd  female  individuals  did  not  show  signiﬁcant  effects  of
aplotype  regardless  of  maltreatment  (all  P-values  >0.36).
igniﬁcant  effects  of  childhood  maltreatment  were  found  in
ll  analyses  (all  P-values  <0.002).  Mediation  analysis  showed
hat  gender  did  not  causally  inﬂuence  CA  haplotype  mod-
ﬁcation  of  childhood  maltreatment  (mediated  proportion
1%,  P  >  0.9).
Mineralocorticoid  receptor  haplotypes  sex-dependently  moderate  depression  95
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hFig.  1  The  interaction  between  sex,  the  MR  CA  haplotype  and
based sample  (A,  BDI  score,  P  =  0.029)  and  in  the  clinical  sampl
3.3.  Sex-dependence  of  MR  haplotypes  on
depressive symptoms  in  the  clinical  sample
In  the  clinical  sample,  there  was  a  signiﬁcant  sex-dependent
association  in  the  relation  between  childhood  maltreatment
and  depressive  symptoms  (IDS  score)  for  the  CA  haplotype
(sex  ×  maltreatment  ×  haplotype,  ˇ  =  −2.41,  P  =  0.010)  and
the  CG  haplotype  (sex  ×  maltreatment  ×  haplotype,
ˇ  =  3.00,  P  =  0.020)  but  not  for  the  GA  haplotype
(sex  ×  maltreatment  ×  haplotype,  ˇ  =  0.90,  P  =  0.34)
(Table  3,  Fig.  1B).  Childhood  maltreatment  was  signif-
icantly  associated  with  depressive  symptoms  in  all  analyses
(P  <  0.05).  Analysis  of  the  separate  SNPs  showed  that
c
v
mhood  maltreatment  on  depressive  symptoms  in  the  population-
 IDS  score,  P  =  0.010).
he  three-way  interaction  between  sex,  maltreatment
nd  the  separate  SNPs  was  not  signiﬁcant  for  rs2070951
sex  ×  maltreatment  ×  rs2070951  interaction,  P  =  0.34)  but
as  signiﬁcant  for  rs5522  (sex  ×  maltreatment  ×  rs5522
nteraction,  P  =  0.020).
Subsequently,  male  and  female  individuals  were  ana-
yzed  separately.  Childhood  maltreatment  was  associated
ith  increased  depressive  symptoms  for  male  CA  hap-
otype  carriers  (ˇ  = 2.54,  P  =  0.0022),  whereas  male  CG
aplotype  carriers  were  protected  (ˇ  =  −2.71,  P  =  0.016).  In
ontrast,  no  signiﬁcant  effects  were  found  in  female  indi-
iduals  for  the  CA  haplotype  (haplotype:  ˇ  =  −1.01,  P  =  0.21;
altreatment  ×  haplotype  interaction:  ˇ  =  0.14,  P  =  0.78)  or
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Table  3  The  relation  between  MR  haplotypes,  sex,  and  childhood  maltreatment  on  depressive  symptoms  (IDS  score)  in  the
clinical sample  (N  =  1639)  for  the  GA  haplotype  (A),  the  MR  CA  haplotype  (B),  and  the  CG  haplotype  (C).
(A)  MR  GA  (1)  haplotype
Sample  Beta  SE  t-Value  P  value
Intercept  20.49  1.70  12.07  <0.001
Sex −0.06  0.03  −2.20  0.028*
Age  −0.66  1.62  −0.40  0.69
childhood maltreatment  4.93  1.06  5.23  <0.001***
MR  GA  haplotype  0.49  2.04  0.46  0.64
Sex ×  maltreatment  −0.23  1.13  −0.21  0.84
Sex ×  GA  haplotype 0.27 1.32 0.20  0.84
Maltreatment  ×  GA  haplotype −1.16 0.80 −1.45 0.15
Sex  ×  maltreatment  ×  GA  haplotype  0.90  0.95  0.95  0.34
(B) MR  CA  (2)  haplotype
Intercept  22.95  1.61  14.21  <0.001
Sex −0.06  0.03  −2.23  0.026*
Age  −1.55  1.36  −1.13  0.26
Childhood maltreatment 1.91  0.79  2.42  0.015*
MR  CA  haplotype −2.55 1.08  −2.36  0.018*
Sex  ×  maltreatment 2.43 0.94 2.57  0.010*
Sex  ×  CA  haplotype 1.54 1.36  1.13  0.26
Maltreatment  ×  CA  haplotype 2.55 0.78 3.27  0.001**
Sex  ×  maltreatment  ×  CA  haplotype −2.41 0.94  −2.57  0.010*
C:  MR  CG  (3)  haplotype
Intercept  19.93  1.39  14.29  <0.001
Sex −0.06  0.03  −2.24  0.025*
Age  0.70  1.01  0.69  0.49
Childhood maltreatment  4.56  0.62  7.39  <0.001***
MR  CG  haplotype  4.17  1.53  2.73  0.007*
Sex  ×  maltreatment  −0.22  0.72  −0.31  0.76
Sex ×  CG  haplotype  −3.80  1.94  −1.96  0.05
Maltreatment  ×  CG  haplotype  −2.72  1.06  −2.56  0.011*
Sex  ×  maltreatment  ×  CG  haplotype  3.00  1.28  2.33  0.020*
* P < 0.05.
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*** P < 0.001.
he  CG  haplotype  (haplotype:  ˇ  =  0.36,  P  =  0.75;  maltreat-
ent  ×  haplotype  interaction:  ˇ  =  0.29,  P  =  0.69).  For  the  GA
aplotype,  separate  analysis  of  males  and  females  did  not
how  signiﬁcant  effects  of  haplotype  regardless  of  maltreat-
ent  (all  P-values  >0.17).  For  all  haplotypes,  signiﬁcant
ffects  of  childhood  maltreatment  were  found  (P  <  0.001).
ediation  analysis  showed  that  gender  did  not  causally  inﬂu-
nce  CA  haplotype  modiﬁcation  of  childhood  maltreatment
mediated  proportion  <1%,  P  >  0.9).
Inclusion  of  antidepressant  use  as  covariate  did  not
hange  any  of  the  results  rather  than  enhancing  the  sex-
ependent  effects  of  the  CA  haplotype  (ˇ  =  −2.36,  P  =  0.008)
nd  the  CG  haplotype  (ˇ  =  3.00,  P  =  0.004).
.4.  Sex-dependence  of  MR  haplotypes  on  lifetime
DD in  the  clinical  sample
ith  lifetime  MDD  as  outcome,  sex  differences  with
egard  to  the  association  between  maltreatment  and
(
t
o
PDD  nearly  reached  statistical  signiﬁcance  for  the  CA
aplotype  (sex  ×  maltreatment  ×  haplotype  interaction
 =  −0.49,  P  =  0.06)  and  an  overall  CA  haplotype  effect
or  maltreatment-related  MDD  (maltreatment  ×  haplotype
nteraction,  ˇ  =  0.62,  P  =  0.005).  For  the  CG  haplotype,
ex  differences  were  also  observed  (sex  ×  haplotype
nteraction  ˇ  =  −0.68,  P  =  0.04)  even  though  this
ffect  appeared  to  be  independent  of  maltreatment
sex  ×  maltreatment  ×  haplotype  interaction  ˇ  =  0.36,
 =  0.29).  For  the  GA  haplotype,  no  signiﬁcant  sex  dif-
erences  were  observed,  even  though  this  haplotype
as  signiﬁcantly  associated  with  maltreatment-related
ifetime  MDD  (maltreatment  ×  haplotype  interaction,
 =  −0.44,  P  =  0.025).  Analysis  of  the  separate  SNPs
howed  no  signiﬁcant  3-way  interaction  for  rs2070951
sex  ×  maltreatment  ×  rs2070951,  P  =  0.27),  even  though
here  were  signiﬁcant  maltreatment-related  effects
f  rs2070951  (maltreatment  ×  rs2070951  interaction,
 =  0.025).  Moreover,  no  signiﬁcant  3-way  interaction  was
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found  for  rs5522  (sex  ×  maltreatment  ×  rs5522,  P  =  0.29),
even  though  sex-dependent  effects  independent  of
maltreatment  were  present  (sex  ×  rs5522  interaction,
P  =  0.044).
Subsequently,  we  analyzed  male  and  female  individ-
uals  separately.  Childhood  maltreatment  was  associated
with  decreased  MDD  risk  for  male  GA  haplotype  carriers
(ˇ  =  −0.44,  P  =  0.025),  whereas  male  CA  haplotype  carriers
were  more  vulnerable  following  maltreatment  (ˇ  =  −0.62,
P  =  0.005).  For  the  CG  haplotype,  no  signiﬁcant  effects  of
haplotype  were  found  in  males  regardless  of  maltreatment.
In  contrast,  no  signiﬁcant  effects  were  found  in  female
individuals  for  the  GA  haplotype  (haplotype:  ˇ  =  0.25,
P  =  0.07;  maltreatment  ×  haplotype  interaction:  ˇ  =  −0.17,
P  =  0.23),  the  CA  haplotype  (haplotype:  ˇ  =  −0.20,  P  =  0.17;
maltreatment  ×  haplotype  interaction:  ˇ  =  0.12,  P  =  0.40),  or
the  CG  haplotype  (haplotype:  ˇ  =  −0.17,  P  =  0.40;  maltreat-
ment  ×  haplotype  interaction:  ˇ  =  0.13,  P  =  0.56).
In  all  analyses,  signiﬁcant  effects  of  childhood  maltreat-
ment  were  found  (P  <  0.001).  For  all  analyses,  inclusion  of
current  antidepressant  use  as  covariate  did  not  change  any
of  the  results.
3.5.  Main  analysis  and  two-way  interactions  for
the CA  haplotype  in  both  samples
The  CA  haplotype  most  unambiguously  presents  the  inter-
action  in  the  two  samples.  To  enhance  the  interpretation
of  the  three-way  interactions,  we  have  also  reported  the
main  and  2-way  interactions  for  the  CA  haplotype.  This
CA  haplotype  shows  signiﬁcant  two-way  interactions  with
childhood  maltreatment  in  the  population-based  and  clini-
cal  sample.  In  Supplemental  Tables  S2—S4,  detailed  models
on  the  main  effects  and  the  2-way  interactions  for  both
the  population-based  (depressive  symptoms)  and  the  clin-
ical  sample  (depressive  symptoms  and  lifetime  MDD)  are
presented.  Moreover,  ﬁgures  displaying  the  means  for  the
3-way  interaction  of  the  CA,  GA  and  CG  haplotype  have
been  included  in  the  Supplementary  material,  with  child-
hood  maltreatment  as  a  dichotomous  outcome  (rather  than
a  continuous  indicator  as  used  in  the  main  analyses)  to
enhance  the  interpretation  of  our  data  (Supplementary  Figs.
S1—S5).
3.6.  MR  diplotype  analyses  in  both  samples
In  addition  to  the  effect  of  MR  haplotypes,  the  con-
tribution  of  MR  diplotypes  (speciﬁc  combinations  of
haplotypes)  was  also  studied  in  both  samples  using
depressive  symptoms  as  outcome.  Compared  to  the  most
common  GA/CA  diplotype,  consistent  sex-dependent
effects  were  found  for  the  GA/GA  diplotype  in  the
population-based  sample  (sex  ×  maltreatment  ×  diplotype
interaction  ˇ  =  13.39,  P  <  0.001,  sex  ×  diplotype  inter-
action  ˇ  =  −15.54,  P  <  0.001)  and  the  clinical  sample
(sex  ×  maltreatment  ×  diplotype  interaction  ˇ  =  4.91,
P  =  0.004)  (see  Supplementary  Table  S5).  In  the  clini-
cal  sample,  the  CG/CG  (sex  ×  maltreatment  ×  diplotype
interaction  ˇ  =  11.02,  P  =  0.011)  and  CG/CA  diplotype
(sex  ×  maltreatment  ×  diplotype  interaction  ˇ  =  3.98,
P  =  0.041)  signiﬁcantly  moderated  the  relation  between
a
—
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altreatment  and  depressive  symptoms,  consistent  with
he  signiﬁcant  sex-dependent  effects  of  the  CG  haplotype
n  this  sample  (see  Section  3.3).  The  results  of  the  CG/CG
iplotype  should  be  cautiously  interpreted  since  only  a  few
ndividuals  possess  the  diplotype  (Supplementary  Table  S1).
.7.  Likelihood  ratio  test  with  sex  as  additional
actor
n  the  population-based  sample,  models  with  sex  had  a
uperior  ﬁt  over  models  without  sex  for  the  GA  and  CA,
ut  not  the  CG  haplotype  (GA  haplotype:  F(657,  4)  =  4.11,
 =  0.0027,  CA  haplotype:  F(657,  4)  =  2.74,  P  =  0.028,  CG  hap-
otype:  F(657,  4)  =  1.14,  P  =  0.34).  For  the  clinical  sample,
odels  with  sex  had  a  superior  ﬁt  only  for  the  GA  haplotype
GA  haplotype:  F(1280,  4)  =  2.37,  P  =  0.050,  CA  haplotype:
(1280,  4)  =  1.38,  P  =  0.24,  CG  haplotype:  F(1280,  4)  =  0.877,
 =  0.48).
.  Discussion
he  present  study  shows  that  the  interaction  between
hildhood  maltreatment  and  functional  MR  haplotypes  in
etermining  depression  susceptibility  is  sex-dependent.
hese  data  therefore  indicate  that  sex  is  an  important  factor
n  determining  whether  functional  MR  haplotypes  are  beneﬁ-
ial  or  detrimental.  Across  samples,  the  CA  haplotype  seems
o  present  either  females  with  an  advantage  (the  discovery
ample)  or  males  at  a disadvantage  (the  replication  sam-
le),  whereas  the  opposite  is  apparent  for  the  GA  and  CG
aplotype  (Tables  2  and  3).
.1.  Focus  on  MR
his  study  focused  on  the  potential  role  of  the  MR  since  this
eceptor  has  emerged  as  an  important  moderator  of  stress,
egardless  of  sex  (Rozeboom  et  al.,  2007).  Preclinical  data
uggest  that  increased  MR  expression  in  the  limbic  system
ay  translate  to  a  more  favorable  strategy  to  appraise  and
espond  to  a  novel  and  potentially  stressful  situation  (Ter
orst  et  al.,  2012).  In  rodents,  antidepressants  induce  hip-
ocampal  MR  activity  (Bjartmar  et  al.,  2000;  Seckl  and  Fink,
992).  Moreover,  in  humans,  the  response  to  antidepressants
or  MDD  was  found  to  be  accelerated  by  the  MR  agonist  ﬂu-
rocortisone  (Otte  et  al.,  2010).  The  mechanisms  underlying
hese  MR  actions  remain  to  be  established.  The  high  corti-
ol  afﬁnity  of  MR  contributes  to  the  fact  that  in  the  brain  —
here  other  binding  proteins  including  cortisol-binding  glob-
lins  are  absent  —  cortisol  levels  remain  relatively  low  under
asal  conditions  and  do  not  ‘‘overshoot’’  under  stressful  cir-
umstances.  This  may  in  part  explain  why  deletion  of  the
R  in  rodents  results  in  decreased  neuronal  viability  in  the
imbic  system.  However,  the  MR  also  exerts  rapid  effects
n  neurotransmission  and  synaptic  plasticity  in  the  amyg-
ala  and  hippocampus  under  stressful  circumstances  (Karst
t  al.,  2010,  2005).  Overall,  the  MR  exerts  slow  genomic
ctions  on  the  one  hand,  determining  —  among  other  things
 the  threshold  of  the  stress  response  and  neuronal  viabil-
ty.  On  the  other  hand,  there  are  rapid  non-genomic  actions
f  the  MR  which  are  thought  to  inﬂuence  the  appraisal  of
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28  
n  acute  stressful  situation  (DeRijk  et  al.,  2008;  Ter  Heegde
t  al.,  2015;  Reul  et  al.,  2000).
.2.  MR  genetic  variation  causes  sex-dependent
ffects
he  sex-dependent  results  should  be  interpreted  in  light
f  the  different  functionality  of  the  haplotypes.  First,  the
A  haplotype  shows  a  signiﬁcant  lower  maximal  transac-
ivation  and  a  lower  protein  expression  compared  to  the
A  and  CG  haplotypes.  Tests  of  the  promoter  region  of
he  three  haplotypes  in  vitro  revealed  different  activities
nder  basal  non-stimulated  conditions,  with  the  GA  hap-
otype  having  the  highest  activity  and  the  CG  haplotype
he  lowest  (Klok  et  al.,  2011b).  Therefore,  loss  of  func-
ion,  differential  translational  activity  and  promoter  activity
ll  contribute  to  the  variability  of  in  vivo  MR-expression
nd  activity  with  regard  to  these  two  exon  SNPs.  It  is
urrently  unknown  how  sex  differences  relate  to  these
unctional  differences.  However,  the  female  steroid  hor-
one  progesterone  binds  to  the  MR,  and  both  estrogen
nd  progesterone  can  inﬂuence  MR  expression  levels  (Carey
t  al.,  1995;  Quinkler  et  al.,  2002).  Thus,  estrogen  has
een  found  to  decrease  hippocampal  MR  transcription  in
emale  rats,  using  a  solution-hybridization  RNase  protec-
ion  assay  (Burgess  and  Handa,  1993).  This  estrogen-induced
ecrease  in  MR  transcription  was  conﬁrmed  for  all  hip-
ocampal  subﬁelds  with  in  situ  hybridization  and  found  to
esult  in  decreased  MR  binding  capacity  (Carey  et  al.,  1995).
herefore,  the  MR  CA  haplotype  —  which  is  associated  with
ncreased  MR  expression  and  activity  —  may  provide  at  least
artial  compensatory  enhancement  of  the  MR  function  in
emales  and  this  compensatory  action  is  expected  to  be
articularly  effective  in  females.  Interestingly,  (neonatal)
ndrogen  treatment  caused  an  upregulation  of  hippocampal
R  expression  in  male  rats  (Karimi  et  al.,  2013).  In  analogy  to
he  situation  proposed  above  for  female  rats,  the  relatively
ow  MR  expression  associated  with  the  GA  haplotype  may
ompensate  for  this  androgen-induced  MR  upregulation  par-
icularly  in  male  individuals.
Sex-dependent  effects  related  to  the  HPA-axis  in  connec-
ion  with  genetic  variations  in  MR  are  not  unprecedented.
or  instance,  dexamethasone  suppression  of  the  CAR  was
ighest  in  female  carriers  of  the  GA  haplotype  whereas  male
A  haplotype  carriers  showed  an  attenuated  suppression
Leeuwen  et  al.,  2010).  Also,  female  but  not  male  homozy-
otic  C-carriers  of  rs2070951  (present  in  the  CA  and  CG
aplotype)  had  an  attenuated  increase  of  the  cortisol  awak-
ning  response  (Klok  et  al.,  2011c).  Sex  differences  have
lso  been  reported  for  MR  mRNA  levels  in  the  human  hip-
ocampus,  with  higher  concentrations  in  women  compared
o  men  (Watzka  et  al.,  2000).  Despite  the  increasing  evi-
ence  for  sex  differences  in  MR  functionality  and  expression
n  humans,  the  molecular  background  of  these  differences
ppears  to  be  diverse  and  is  not  yet  fully  understood.
.3.  Relevance  for  psychopathologyven  though  robust  sex  differences  exist  in  depres-
ion  incidence  (Cyranowski  et  al.,  2000;  Piccinelli  and
ilkinson,  2000)  and  HPA-axis  activity  (Kirschbaum  et  al.,
s
a
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999;  Kudielka  and  Kirschbaum,  2005),  the  role  in  gene-
nvironment  studies  has  received  relatively  little  attention
n  the  literature.  This  study  adds  to  the  paucity  of  data  by
howing  that  MR  haplotypes  sex-dependently  inﬂuence  the
ssociation  between  childhood  maltreatment  and  depres-
ive  symptoms  in  two  independent  samples.  However,  it  is
mportant  to  note  that  the  MR  alone  cannot  explain  the
arge  sex  differences  in  depression,  notwithstanding  the  fact
hat  a  female  vulnerability  was  found  in  the  most  prevalent
aplotype.  Rather,  genetic  variation  in  the  MR  can  only  con-
ribute  to  our  knowledge  together  with  other  genes,  and  sex
ifferences  are  likely  to  be  polygenic.  From  a  broader  per-
pective,  our  results  ﬁt  earlier  twin  studies  that  have  found
vidence  for  sex  differences  in  the  genetic  risk  for  depres-
ion  (Kendler  et  al.,  2001,  2006).  Moreover,  our  ﬁnding  that
he  effects  of  MR  haplotypes  on  depression  seem  to  emerge
fter  exposure  to  childhood  maltreatment  supports  and
xtends  the  recent  ﬁnding  that  the  MR  CA  haplotype  is  asso-
iated  with  reduced  chances  on  depression  and  enhanced
ptimism  in  females  but  not  in  males  (Klok  et  al.,  2011b).
urthermore,  these  maltreatment-induced  MR  effects  are
onsistent  with  the  observation  that  early  adversity  has  a
arge  effect  on  HPA  axis  activity  (Heim  and  Nemeroff,  2001).
Sex-dependent  MR  effects  of  maltreatment-related
epressive  symptoms  are  supported  by  three  converging
ines  of  evidence.  First,  sex-dependent  effects  are  plau-
ible  from  a  biological  perspective  as  the  female  steroid
ormones  estrogen  and  progesterone  both  display  MR  afﬁn-
ty  and  can  affect  HPA  axis  activity  (Carey  et  al.,  1995;
uinkler  et  al.,  2002).  Moreover,  progesterone  and  estrogen
an  affect  MR  expression  (Castrén  et  al.,  1995;  Turner,  1990).
oreover,  the  estrogen  receptor  was  found  to  inhibit  trans-
ctivational  MR  activity  across  cell  types  (Barrett  Mueller
t  al.,  2014).  Sex-speciﬁc  effects  may  be  particularly  visi-
le  during  speciﬁc  phases  of  the  menstrual  cycle,  since  both
R-deﬁcient  and  stressed  female  mice  show  an  improved
erformance  in  the  estrus  phase  (Ter  Horst  et  al.,  2012).
Second,  preclinical  studies  suggest  that  the  regulation  of
R  expression  and  the  subsequent  behavioral  and  molecular
onsequences  are  gender-dependent.  In  a fear-conditioned
emory  test,  female  but  not  male  MR-deﬁcient  mice  were
nable  to  extinguish  fear  memory  (Ter  Horst  et  al.,  2012).
urthermore,  after  14  days  of  restraint  stress,  female  rats
howed  an  upregulation  of  hippocampal  MR  (but  unaltered
R)  whereas  male  rats  displayed  limited  MR  downregulation
but  downregulated  GR)  (Karandrea  et  al.,  2000).  More-
ver,  hippocampal  MR  expression  in  the  CA3  was  speciﬁcally
ncreased  in  female  rats  accompanied  by  an  enhanced  mem-
ry  performance  (Kitraki  et  al.,  2004).  In  contrast,  15  days  of
hronic  unpredictable  stress  in  young  rats  sex-dependently
ffected  MR  expression  in  a  opposite  manner,  with  female
ats  having  a  downregulated  MR  but  male  rats  an  upregu-
ated  MR  (Llorente  et  al.,  2011).  This  discrepancy  could  be
xplained  by  the  difference  in  the  stress  protocol  and  the
ge  at  which  it  was  applied  Rats  were  sacriﬁced  47  days  after
tress  in  the  ﬁrst  study  (Llorente  et  al.,  2011),  but  directly
fter  the  stressor  in  the  other  two  studies  (Karandrea  et  al.,
000;  Kitraki  et  al.,  2004).  Despite  this  discrepancy,  the
tudies  share  the  ﬁnding  that  sex-speciﬁc  MR  effects  emerge
fter  chronic  stress  exposure.
Finally,  even  though  the  number  of  clinical  studies  exam-
ning  sex  effects  are  limited,  resilience  to  depression  was
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previously  associated  with  the  MR  CA  haplotype  in  females
only  (Klok  et  al.,  2011b).  Research  into  sex-dependent
effects  of  the  GA  and  CG  haplotype  are  scarce.  However,
sex-dependent  effect  of  the  GA  haplotype  on  dexametha-
sone  suppression  have  been  found  with  an  enhanced  sup-
pression  of  the  cortisol  awakening  response  in  female  car-
riers  (Leeuwen  et  al.,  2010).  Together,  these  studies  under-
score  that  the  MR  may  play  an  important  role  in  determining
sex  differences  in  stress  reactivity  and  subsequent  suscep-
tibility  to  develop  depression,  and  support  a  particular  role
for  the  MR  after  exposure  to  chronic  or  traumatic  stress.
Even  though  the  sex-by-genotype  interactions  were
generally  consistent  between  the  population  and  clinical
sample,  the  effects  of  the  CA  haplotype  appear  to  be  the
result  of  increased  resilience  in  females  in  the  popula-
tion  sample,  whereas  male  CA  haplotype  carriers  display
an  increased  vulnerability  for  depression  in  the  clinical
sample.  Moreover,  there  was  no  signiﬁcant  sex-dependent
effect  of  the  GA  haplotype  in  the  clinical  sample  for  depres-
sive  symptoms,  even  though  a  signiﬁcant  effect  was  found
using  lifetime  MDD  as  outcome  (Table  4).  Nevertheless,
even  though  the  diplotype  results  should  be  cautiously
interpreted  in  light  of  the  limited  power,  the  GA/GA  diplo-
type  resulted  in  sex-dependent  susceptibility  for  depressive
symptoms  after  childhood  maltreatment  in  both  samples.
Also,  no  sex-dependent  effect  of  the  CG  haplotype  was
observed  in  the  population-based  sample.  There  may  be  sev-
eral  reasons  for  the  observed  differences  between  these
samples.  First,  the  majority  of  the  clinical  sample  was
clinically  depressed.  This  may  be  directly  related  to  MR  func-
tionality  and  explain  some  of  the  differences  to  the  healthy
population  sample.  Indeed,  post-mortem  studies  of  MDD
patients  have  pointed  to  a  consistently  decreased  MR  mRNA
expression  (Klok  et  al.,  2011a;  Lopez  et  al.,  1998;  Medina
et  al.,  2013).  Moreover,  antidepressant  use  may  have  inﬂu-
enced  the  results.  Antidepressants  affect  hippocampal  MR
activity  in  preclinical  studies  (Bjartmar  et  al.,  2000;  Seckl
and  Fink,  1992),  and  the  effects  of  SSRIs  on  cortisol  regula-
tion  have  been  shown  to  depend  on  the  MR  genotype  (Klok
et  al.,  2011c).  Inclusion  of  antidepressant  use  as  a  covariate
did  not  change  any  of  the  results.  However,  our  data  are  not
suitable  to  distinguish  the  effects  of  depression  from  med-
ication  use.  Second,  the  higher  average  age  in  the  clinical
sample  may  also  have  inﬂuenced  our  results.  Older  individ-
uals  display  a  blunted  response  to  acute  pharmacological
interventions  targeted  at  HPA  axis  functionality,  either  with
the  MR  agonist  ﬂudrocortisone  (Otte  et  al.,  2003)  or  the  MR
antagonist  canrenoate  (Giordano  et  al.,  2005).  Third,  the
population-based  sample  may  have  possessed  insufﬁcient
power  to  detect  sex-dependent  effects  of  the  relatively  rare
CG  haplotype  (∼9%).
4.4.  Study  design
The  results  of  the  present  study  should  be  interpreted  in
the  context  of  several  potential  limitations.  First,  since  the
data  are  cross-sectional,  our  results  cannot  provide  infor-
mation  about  the  causality  of  the  relationship  between
childhood  trauma  and  depression.  Second,  childhood  trauma
was  retrospectively  assessed  and  may  be  subject  to  recall
bias  depending  on  personal  characteristics  (Monroe,  2008).
(
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owever,  CTQ  scores  are  stable  over  time  and  have  good
onvergent  and  divergent  validity  (Bernstein  and  Fink,  1998;
ernstein  et  al.,  1994),  and  childhood  trauma  in  the  clini-
al  sample  was  ascertained  with  a  different  scale  using  a
emi-structured  interview.  Third,  depression  may  negatively
nﬂuence  reporting  of  early  life  stress.  Nevertheless,  results
ere  comparable  between  the  population-based  and  clin-
cal  sample,  suggesting  that  a  mood-congruent  recall  bias
annot  completely  explain  our  results.
The  present  study  also  has  several  strengths.  First,  the
ex-dependent  effects  of  the  MR  in  the  relation  between
hildhood  trauma  and  depressive  symptoms  were  found  in
 population-based  sample  but  also  in  a  large  and  indepen-
ent  clinical  sample  containing  both  healthy  and  clinically
epressed  individuals.  Therefore,  sex-dependent  MR  effects
n  maltreatment-related  depressive  symptoms  are  appar-
nt  across  samples.  Second,  the  fact  that  in  the  clinical
ample,  sex-dependent  effects  appeared  to  be  present  with
ifetime  MDD  as  outcome  conﬁrms  that  a persistent  effect
ay  be  present.  Third,  we  studied  functional  and  common
enetic  MR  variation  using  one  of  the  two  known  haplotype
locks  in  NR3C2  based  on  exonic  sequencing  (Leeuwen  et  al.,
010).  The  common  MR  haplotypes  in  this  paper  are  based
n  two  promoter  SNPs  and  are  associated  with  differential
xpression  and  activity  at  the  transcriptional,  translational,
nd  transactivational  level  (DeRijk  et  al.,  2006;  Klok  et  al.,
011b;  Van  Leeuwen  et  al.,  2011).  MR-2G/C  (rs2070951)  is
ocated  2  nucleotides  before  the  translation  site  of  exon  2,
hile  MRI180V  (rs5522)  is  located  within  exon  2  and  results
n  a  substitution  of  isoleucine  for  valine.  Although  the  use
f  biologically  informative  genetic  variants  is  a  strength,
t  does  preclude  exploration  of  other  informative  genetic
ariation  and  as  such  increases  the  risk  for  a  conﬁrmation
ias.
In  conclusion,  this  study  shows  that  common  and  func-
ional  MR  haplotypes  are  sex-dependently  associated  with
epression  following  childhood  maltreatment.  These  ﬁnd-
ngs  are  relevant  in  light  of  the  increased  prevalence  of
ood  disorders  in  women  and  are  biologically  plausible  as
he  MR  is  closely  involved  in  HPA  axis  functionality  and  stress
ppraisal.  Together,  these  results  provide  insight  into  the
eurobiological  background  of  sex  differences  in  depression
isk  after  stress  exposure  and  may  add  to  the  development
f  predictive  tools  for  depression  susceptibility.
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Table  4  The  relation  between  MR  haplotypes,  sex,  and  childhood  maltreatment  on  lifetime  MDD  in  the  clinical  sample  (N  =  1639)
for the  GA  haplotype  (A),  the  MR  CA  haplotype  (B),  and  the  CG  haplotype  (C).
(A)  MR  GA  (1)  haplotype
Sample  Beta  SE  t-Value  P  Value
Intercept  0.80  0.30  2.70  0.01**
Sex  0.12  0.27  0.45  0.66
Age −0.01  0.004  −1.28  0.20
Childhood maltreatment  1.22  0.28  4.40  <0.001***
MR  GA  haplotype  0.15  0.17  0.86  0.39
Sex ×  maltreatment  −0.30  0.33  −0.90  0.37
Sex ×  GA  haplotype 0.11 0.22 0.48  0.63
Maltreatment  ×  GA  haplotype −0.44 0.20 −2.24 0.025*
Sex  ×  maltreatment  ×  GA  haplotype  0.27  0.24  1.10  0.27
(B) MR  CA  (2)  haplotype
Intercept  1.25  0.29  4.30  <0.001***
Sex  0.09  0.23  0.38  0.71
Age −0.01  0.01  −1.32  0.19
Childhood maltreatment 0.35  0.17  2.09  0.04*
MR  CA  haplotype −0.39 0.18  −2.20  0.03*
Sex  ×  maltreatment 0.30 0.22 1.37  0.17
Sex ×  CA  haplotype 0.19 0.23  0.85  0.40
Maltreatment  ×  CA  haplotype 0.62 0.22 2.82  0.0048**
Sex  ×  maltreatment  ×  CA  haplotype −0.49 0.26  −1.86  0.06.
(C) MR  CG  (3)  haplotype
Intercept  0.85  0.25  3.37  <0.001***
Sex  0.40  0.17  2.36  0.02*
Age  −0.01  0.01  −1.36  0.17
Childhood maltreatment  0.79  0.15  5.18  <0.001***
MR  CG  haplotype  0.51  0.27  1.89  0.06.
Sex ×  maltreatment  −0.08  0.19  −0.40  0.69
Sex ×  CG  haplotype  −0.68  0.34  −2.01  0.04*
Maltreatment  ×  CG  haplotype  −0.23  0.26  −0.88  0.38
Sex ×  maltreatment  ×  CG  haplotype  0.36  0.34  1.05  0.29
* P < 0.05.
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*** P < 0.001.
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